1. Home
  2. TMDX vs EFSC Comparison

TMDX vs EFSC Comparison

Compare TMDX & EFSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TMDX
  • EFSC
  • Stock Information
  • Founded
  • TMDX 1998
  • EFSC 1988
  • Country
  • TMDX United States
  • EFSC United States
  • Employees
  • TMDX N/A
  • EFSC N/A
  • Industry
  • TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • EFSC Major Banks
  • Sector
  • TMDX Health Care
  • EFSC Finance
  • Exchange
  • TMDX Nasdaq
  • EFSC Nasdaq
  • Market Cap
  • TMDX 2.4B
  • EFSC 2.2B
  • IPO Year
  • TMDX 2019
  • EFSC 1999
  • Fundamental
  • Price
  • TMDX $71.95
  • EFSC $59.25
  • Analyst Decision
  • TMDX Buy
  • EFSC Strong Buy
  • Analyst Count
  • TMDX 11
  • EFSC 3
  • Target Price
  • TMDX $116.10
  • EFSC $67.33
  • AVG Volume (30 Days)
  • TMDX 1.3M
  • EFSC 165.7K
  • Earning Date
  • TMDX 02-27-2025
  • EFSC 01-27-2025
  • Dividend Yield
  • TMDX N/A
  • EFSC 1.82%
  • EPS Growth
  • TMDX N/A
  • EFSC N/A
  • EPS
  • TMDX 0.94
  • EFSC 4.83
  • Revenue
  • TMDX $401,090,000.00
  • EFSC $607,337,000.00
  • Revenue This Year
  • TMDX $81.61
  • EFSC N/A
  • Revenue Next Year
  • TMDX $22.52
  • EFSC $2.14
  • P/E Ratio
  • TMDX $76.78
  • EFSC $12.55
  • Revenue Growth
  • TMDX 109.09
  • EFSC 3.73
  • 52 Week Low
  • TMDX $55.00
  • EFSC $37.28
  • 52 Week High
  • TMDX $177.37
  • EFSC $63.13
  • Technical
  • Relative Strength Index (RSI)
  • TMDX 52.52
  • EFSC 48.08
  • Support Level
  • TMDX $66.81
  • EFSC $59.26
  • Resistance Level
  • TMDX $80.00
  • EFSC $61.29
  • Average True Range (ATR)
  • TMDX 4.14
  • EFSC 1.84
  • MACD
  • TMDX 0.57
  • EFSC -0.18
  • Stochastic Oscillator
  • TMDX 48.74
  • EFSC 30.21

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

About EFSC Enterprise Financial Services Corporation

Enterprise Financial Services Corporation is a financial holding company. It offers banking and wealth management services to individuals and business customers located in Arizona, California, Florida, Kansas, Missouri, Nevada, and New Mexico, in addition to loan and deposit production offices throughout the United States. The company offers a broad range of business and personal banking services including wealth management services. Lending services include commercial and industrial, commercial real estate, real estate construction and development, residential real estate, and consumer loans.

Share on Social Networks: